ArticleFrontiers in bioinformatics2025
Deep learning software and revised 2D model to segment bone in micro-CT scans.
Article in Frontiers in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep learning (DL) enables automated bone segmentation in micro-CT datasets but can struggle to generalize across developmental stages, anatomical regions, and imaging conditions. We present BP-2D-03, which is a revised 2D Bone-Pores segmentation model. It was fitted to a dataset comprising 20 micro-CT scans spanning five mammalian species and 142,960 image patches. To manage the substantially larger and more varied dataset, we developed a DL software interface with modules for training ("BONe DLFit"), prediction ("BONe DLPred"), and evaluation ("BONe IoU"). These tools resolve prior issues such as slice-level data leakage, high memory usage, and limited multi-GPU support. Model performance was evaluated through three analyses. First, 5-fold cross-validation with three seeds per fold evaluated baseline robustness and stability. The model showed generally high mean Intersection-over-Union (IoU) with minimal variation across seeds, but performance varied more across folds related to differences in scan composition. These findings show that the baseline model is stable overall but that predictivity can decline for atypical scans. Second, 30 benchmarking experiments tested how model architecture, encoder backbone, and patch size influence segmentation IoU and computational efficiency. U-Net and UNet++ architectures with simple convolutional backbones (e.g., ResNet-18) achieved the highest IoU values, approaching 0.97. Third, cross-platform experiments confirmed that results are consistent across hardware configurations, operating systems, and implementations (Avizo 3D and standalone). Together, these analyses demonstrate that the BONe DL software delivers robust baseline performance and reproducible results across platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.